GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,736,000 | -24.6% | 262,870 | +11.5% | 2.97% | -17.5% |
| Q2 2022 | $10,258,000 | +0.7% | 235,657 | +0.7% | 3.60% | +5.7% |
| Q1 2022 | $10,189,000 | -1.0% | 233,912 | +0.2% | 3.41% | -2.7% |
| Q4 2021 | $10,291,000 | +13.3% | 233,354 | -1.8% | 3.50% | +6.1% |
| Q3 2021 | $9,082,000 | -0.4% | 237,691 | +3.8% | 3.30% | -0.1% |
| Q2 2021 | $9,122,000 | +13.8% | 229,073 | +2.0% | 3.30% | +10.6% |
| Q1 2021 | $8,014,000 | +0.2% | 224,554 | +3.3% | 2.99% | -10.0% |
| Q4 2020 | $8,000,000 | +9.6% | 217,399 | +12.1% | 3.32% | -5.9% |
| Q3 2020 | $7,298,000 | -2.3% | 193,878 | +5.9% | 3.53% | -4.2% |
| Q2 2020 | $7,466,000 | +12.3% | 183,036 | +4.3% | 3.68% | -3.3% |
| Q1 2020 | $6,651,000 | -12.0% | 175,533 | +9.1% | 3.81% | +12.9% |
| Q4 2019 | $7,558,000 | +11.0% | 160,849 | +0.8% | 3.37% | +3.8% |
| Q3 2019 | $6,811,000 | +8.4% | 159,574 | +1.7% | 3.25% | +5.8% |
| Q2 2019 | $6,282,000 | -3.6% | 156,968 | +0.6% | 3.07% | -4.4% |
| Q1 2019 | $6,519,000 | +28.3% | 155,988 | +17.3% | 3.22% | +13.4% |
| Q4 2018 | $5,080,000 | -4.3% | 132,940 | +0.6% | 2.84% | +4.7% |
| Q3 2018 | $5,307,000 | +0.6% | 132,111 | +1.0% | 2.71% | -6.7% |
| Q2 2018 | $5,274,000 | +3.4% | 130,826 | +0.2% | 2.90% | +2.2% |
| Q1 2018 | $5,099,000 | +11.4% | 130,520 | +1.1% | 2.84% | +16.4% |
| Q4 2017 | $4,579,000 | -15.3% | 129,102 | -3.1% | 2.44% | -20.4% |
| Q3 2017 | $5,409,000 | -4.2% | 133,216 | +1.7% | 3.07% | -10.3% |
| Q2 2017 | $5,649,000 | +3.5% | 131,006 | +1.2% | 3.42% | +0.9% |
| Q1 2017 | $5,459,000 | +17.4% | 129,492 | +7.3% | 3.39% | +11.7% |
| Q4 2016 | $4,648,000 | -10.7% | 120,705 | 0.0% | 3.04% | -11.2% |
| Q3 2016 | $5,206,000 | +0.3% | 120,705 | +0.8% | 3.42% | -2.7% |
| Q2 2016 | $5,189,000 | +8.7% | 119,727 | +1.7% | 3.51% | +2.8% |
| Q1 2016 | $4,775,000 | +0.6% | 117,762 | +0.2% | 3.42% | -4.9% |
| Q4 2015 | $4,745,000 | +5.1% | 117,585 | +0.1% | 3.59% | -1.6% |
| Q3 2015 | $4,516,000 | -4.9% | 117,463 | +3.1% | 3.65% | +0.4% |
| Q2 2015 | $4,748,000 | -6.7% | 113,986 | +3.4% | 3.64% | -6.0% |
| Q1 2015 | $5,089,000 | +60.6% | 110,268 | +48.8% | 3.87% | +65.6% |
| Q4 2014 | $3,168,000 | -7.3% | 74,112 | -0.3% | 2.34% | -9.4% |
| Q3 2014 | $3,417,000 | -14.0% | 74,338 | +0.0% | 2.58% | -13.8% |
| Q2 2014 | $3,974,000 | -0.7% | 74,305 | -0.8% | 2.99% | -3.4% |
| Q1 2014 | $4,003,000 | +0.6% | 74,919 | +0.5% | 3.10% | -2.7% |
| Q4 2013 | $3,981,000 | – | 74,573 | – | 3.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |